A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
RasCal Therapeutics, Inc.
Filamon LTD
AstraZeneca
Hoffmann-La Roche
UMC Utrecht
Essen Biotech
St. Jude Children's Research Hospital
xCures
Swansea Bay University Health Board
University of Nebraska
Adela, Inc
Var2 Pharmaceuticals
Mayo Clinic
Mayo Clinic
Dana-Farber Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Incyte Corporation
Day One Biopharmaceuticals, Inc.
AVM Biotechnology Inc
LigaChem Biosciences, Inc.
Ikena Oncology
Washington University School of Medicine
Day One Biopharmaceuticals, Inc.
Jonsson Comprehensive Cancer Center
Azienda Ospedaliera di Padova
Apollomics Inc.
Columbia University
Tempus AI
Stanford University
Cedars-Sinai Medical Center
BerGenBio ASA
Universidade Federal de Pernambuco
ABM Therapeutics Corporation
Actuate Therapeutics Inc.
Wake Forest University Health Sciences
Mayo Clinic
University of Sydney
Cedars-Sinai Medical Center
Sumitomo Pharma America, Inc.
Quadriga Biosciences, Inc.
Technische Universität Dresden
Health Clinics Limited
Five Prime Therapeutics, Inc.
Weill Medical College of Cornell University
Gilead Sciences
Hospices Civils de Lyon
SpeciCare
University Hospital Tuebingen
Southwest Hospital, China
Cambridge University Hospitals NHS Foundation Trust